ABVC Biopharma Inc (ABVC)

ABVC Biopharma Inc (ABVC) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $26.7M; returns 1 day -0.7%, 1 week +13.3%, 1 year -64.4%.

ABVC BioPharma Inc. (NASDAQ: ABVC) is a clinical-stage biopharmaceutical company headquartered in Fremont, California, focused on identifying and commercializing botanical and plant-derived drugs, alongside a medical device, for unmet medical needs across oncology, central nervous system (CNS) disorders, and ophthalmology.

Groups ABVC belongs to

• Biotechnology
• Biopharmaceutical
• Clinical Stage Biotech
• Clinical Stage Biopharma
• Clinical Stage
• Oncology
• CNS Disorders
• Ophthalmology
• Medical Devices
• Asset-Light Model
• Healthcare
• Unmet Medical Needs

ABVC financial model: income statement, cash flow and balance sheet